Trial intelligence / Profile preview

Citalopram and Brain Metabolites in Major Depression

NCT01557946Phase 4Completed

Sponsor
McLean Hospital
Start
Mar 2012
Primary completion
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of citalopram in major depressive disorder (MDD), sponsored by McLean Hospital. Started Mar 2012; status: completed.

02

Drugs

citalopram
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT01557946.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01557946.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call